Header Logo

Connection

THOMAS KOSTEN to Cocaine

Back to Details
This is a "connection" page, showing publications THOMAS KOSTEN has written about Cocaine.
THOMAS KOSTEN
Connection Strength
12.046
Cocaine
  1. Moderation of buprenorphine therapy for cocaine dependence efficacy by variation of the Prodynorphin gene. Eur J Clin Pharmacol. 2022 Jun; 78(6):965-973.
    View in: PubMed
    Score: 0.665
  2. Current status of vaccines for substance use disorders: A brief review of human studies. J Neurol Sci. 2022 Mar 15; 434:120098.
    View in: PubMed
    Score: 0.656
  3. Dopamine D3 receptor-preferring agonist enhances the subjective effects of cocaine in humans. Psychiatry Res. 2015 Nov 30; 230(1):44-9.
    View in: PubMed
    Score: 0.421
  4. The future potential for cocaine vaccines. Expert Opin Biol Ther. 2014 Sep; 14(9):1271-83.
    View in: PubMed
    Score: 0.388
  5. Prospects, promise and problems on the road to effective vaccines and related therapies for substance abuse. Expert Rev Vaccines. 2013 Mar; 12(3):323-32.
    View in: PubMed
    Score: 0.356
  6. DBH gene as predictor of response in a cocaine vaccine clinical trial. Neurosci Lett. 2013 Apr 29; 541:29-33.
    View in: PubMed
    Score: 0.356
  7. Spontaneous development of IgM anti-cocaine antibodies in habitual cocaine users: effect on IgG antibody responses to a cocaine cholera toxin B conjugate vaccine. Am J Addict. 2013 Mar-Apr; 22(2):169-74.
    View in: PubMed
    Score: 0.355
  8. Epigenetics of drug abuse: predisposition or response. Pharmacogenomics. 2012 Jul; 13(10):1149-60.
    View in: PubMed
    Score: 0.340
  9. Vaccines for cocaine abuse. Hum Vaccin. 2009 Apr; 5(4):194-9.
    View in: PubMed
    Score: 0.273
  10. Sex differences in non-reinforced responding for cocaine. Am J Drug Alcohol Abuse. 2008; 34(4):473-88.
    View in: PubMed
    Score: 0.249
  11. Tiagabine affects the subjective responses to cocaine in humans. Pharmacol Biochem Behav. 2005 Nov; 82(3):569-73.
    View in: PubMed
    Score: 0.216
  12. Vaccine pharmacotherapy for the treatment of cocaine dependence. Biol Psychiatry. 2005 Jul 15; 58(2):158-64.
    View in: PubMed
    Score: 0.210
  13. Cortical excitability in cocaine-dependent patients: a replication and extension of TMS findings. J Psychiatr Res. 2005 May; 39(3):295-302.
    View in: PubMed
    Score: 0.207
  14. Desipramine treatment for cocaine dependence in buprenorphine- or methadone-treated patients: baseline urine results as predictor of response. Am J Addict. 2005 Jan-Feb; 14(1):8-17.
    View in: PubMed
    Score: 0.202
  15. Human therapeutic cocaine vaccine: safety and immunogenicity. Vaccine. 2002 Jan 15; 20(7-8):1196-204.
    View in: PubMed
    Score: 0.165
  16. Effects of cocaine prior to and during bupropion maintenance in cocaine-abusing volunteers. Drug Alcohol Depend. 2001 Jul 01; 63(2):155-67.
    View in: PubMed
    Score: 0.159
  17. Significant interaction between clozapine and cocaine in cocaine addicts. Drug Alcohol Depend. 2000 May 01; 59(2):153-63.
    View in: PubMed
    Score: 0.146
  18. Current status of immunotherapies for addiction. Ann N Y Acad Sci. 2021 04; 1489(1):3-16.
    View in: PubMed
    Score: 0.145
  19. Interactions of cocaine with nimodipine: a brief report. Am J Addict. 1999; 8(1):77-81.
    View in: PubMed
    Score: 0.134
  20. FAAH variant Pro129Thr modulates subjective effects produced by cocaine administration. Am J Addict. 2018 10; 27(7):567-573.
    View in: PubMed
    Score: 0.130
  21. A comprehensive pharmacologic-psychosocial treatment program for HIV-seropositive cocaine- and opioid-dependent patients. Preliminary findings. J Subst Abuse Treat. 1998 May-Jun; 15(3):261-5.
    View in: PubMed
    Score: 0.127
  22. Regional cerebral blood flow during acute and chronic abstinence from combined cocaine-alcohol abuse. Drug Alcohol Depend. 1998 May 01; 50(3):187-95.
    View in: PubMed
    Score: 0.127
  23. Effects of d-amphetamine and caffeine in humans under a cocaine discrimination procedure. Behav Pharmacol. 1998 May; 9(3):207-17.
    View in: PubMed
    Score: 0.127
  24. Plasma homovanillic acid and the dopamine transporter during cocaine withdrawal. Biol Psychiatry. 1998 Feb 15; 43(4):278-81.
    View in: PubMed
    Score: 0.126
  25. Pharmacotherapy of cerebral ischemia in cocaine dependence. Drug Alcohol Depend. 1998 Jan 01; 49(2):133-44.
    View in: PubMed
    Score: 0.125
  26. Buprenorphine vs methadone maintenance treatment for concurrent opioid dependence and cocaine abuse. Arch Gen Psychiatry. 1997 Aug; 54(8):713-20.
    View in: PubMed
    Score: 0.121
  27. Acute cocaine effects on absolute cerebral blood flow. Psychopharmacology (Berl). 1996 Nov; 128(1):17-20.
    View in: PubMed
    Score: 0.115
  28. The a-1 adrenoceptor (ADRA1A) genotype moderates the magnitude of acute cocaine-induced subjective effects in cocaine-dependent individuals. Pharmacogenet Genomics. 2016 09; 26(9):428-35.
    View in: PubMed
    Score: 0.114
  29. Abstinence symptomatology associated with cessation of chronic cocaine abuse among methadone-maintained patients. Am J Drug Alcohol Abuse. 1996 Aug; 22(3):377-88.
    View in: PubMed
    Score: 0.113
  30. Pemoline for the treatment of cocaine dependence in methadone-maintained patients. J Psychoactive Drugs. 1996 Jul-Sep; 28(3):301-4.
    View in: PubMed
    Score: 0.112
  31. Gender differences in response to intranasal cocaine administration to humans. Biol Psychiatry. 1996 Jan 15; 39(2):147-8.
    View in: PubMed
    Score: 0.109
  32. Mazindol for relapse prevention to cocaine abuse in methadone-maintained patients. Am J Drug Alcohol Abuse. 1995 Nov; 21(4):469-81.
    View in: PubMed
    Score: 0.107
  33. Genetic variation of the dopamine transporter (DAT1) influences the acute subjective responses to cocaine in volunteers with cocaine use disorders. Pharmacogenet Genomics. 2015 Jun; 25(6):296-304.
    View in: PubMed
    Score: 0.104
  34. Behavioral, physiological, and pharmacological interaction of cocaine and disulfiram in humans. Biol Psychiatry. 1995 Apr 15; 37(8):560-3.
    View in: PubMed
    Score: 0.103
  35. A single-blind investigation of four auricular needle puncture configurations. Am J Chin Med. 1995; 23(2):105-14.
    View in: PubMed
    Score: 0.101
  36. Reduction of opiate withdrawal-like symptoms by cocaine abuse during methadone and buprenorphine maintenance. Am J Drug Alcohol Abuse. 1994 Nov; 20(4):445-58.
    View in: PubMed
    Score: 0.100
  37. Stimulant withdrawal. Addiction. 1994 Nov; 89(11):1477-81.
    View in: PubMed
    Score: 0.100
  38. Cue-elicited cocaine craving and autogenic relaxation. Association with treatment outcome. J Subst Abuse Treat. 1994 Nov-Dec; 11(6):549-52.
    View in: PubMed
    Score: 0.100
  39. HIV infection and cocaine use in methadone maintained and untreated intravenous drug users. Drug Alcohol Depend. 1994 Oct; 36(2):109-13.
    View in: PubMed
    Score: 0.099
  40. Attenuation of cocaine-induced locomotor activity in male and female mice by active immunization. Am J Addict. 2014 Nov-Dec; 23(6):604-7.
    View in: PubMed
    Score: 0.099
  41. Hapten optimization for cocaine vaccine with improved cocaine recognition. Chem Biol Drug Des. 2014 Sep; 84(3):354-63.
    View in: PubMed
    Score: 0.098
  42. Vaccine for cocaine dependence: a randomized double-blind placebo-controlled efficacy trial. Drug Alcohol Depend. 2014 Jul 01; 140:42-7.
    View in: PubMed
    Score: 0.096
  43. Cocaine abuse in methadone maintenance programs: integrating pharmacotherapy with psychosocial interventions. J Psychoactive Drugs. 1994 Apr-Jun; 26(2):137-46.
    View in: PubMed
    Score: 0.096
  44. Vaccines against stimulants: cocaine and MA. Br J Clin Pharmacol. 2014 Feb; 77(2):368-74.
    View in: PubMed
    Score: 0.095
  45. Buprenorphine: dose-related effects on cocaine and opioid use in cocaine-abusing opioid-dependent humans. Biol Psychiatry. 1993 Jul 1-15; 34(1-2):66-74.
    View in: PubMed
    Score: 0.091
  46. Effects of sham and real auricular needling: implications for trials of acupuncture for cocaine addiction. Am J Chin Med. 1993; 21(2):103-11.
    View in: PubMed
    Score: 0.088
  47. Clinical and research perspectives on cocaine abuse: the pharmacotherapy of cocaine abuse. NIDA Res Monogr. 1993; 135:48-56.
    View in: PubMed
    Score: 0.088
  48. Gender differences in cocaine use and treatment response. J Subst Abuse Treat. 1993 Jan-Feb; 10(1):63-6.
    View in: PubMed
    Score: 0.088
  49. The impact of disulfiram treatment on the reinforcing effects of cocaine: a randomized clinical trial. PLoS One. 2012; 7(11):e47702.
    View in: PubMed
    Score: 0.087
  50. Pharmacotherapy for cocaine-abusing methadone-maintained patients using amantadine or desipramine. Arch Gen Psychiatry. 1992 Nov; 49(11):894-8.
    View in: PubMed
    Score: 0.087
  51. Anti-cocaine antibody and butyrylcholinesterase-derived cocaine hydrolase exert cooperative effects on cocaine pharmacokinetics and cocaine-induced locomotor activity in mice. Chem Biol Interact. 2013 Mar 25; 203(1):212-6.
    View in: PubMed
    Score: 0.086
  52. Effects of anti-cocaine vaccine and viral gene transfer of cocaine hydrolase in mice on cocaine toxicity including motor strength and liver damage. Chem Biol Interact. 2013 Mar 25; 203(1):208-11.
    View in: PubMed
    Score: 0.086
  53. Probing cocaine-antibody interactions in buffer and human serum. PLoS One. 2012; 7(7):e40518.
    View in: PubMed
    Score: 0.085
  54. Noradrenergic a1 receptor antagonist treatment attenuates positive subjective effects of cocaine in humans: a randomized trial. PLoS One. 2012; 7(2):e30854.
    View in: PubMed
    Score: 0.083
  55. Alcohol and cocaine abuse. A comparison of epidemiology and clinical characteristics. Recent Dev Alcohol. 1992; 10:115-28.
    View in: PubMed
    Score: 0.082
  56. Pharmacological approaches to cocaine dependence. Clin Neuropharmacol. 1992; 15 Suppl 1 Pt A:70A-71A.
    View in: PubMed
    Score: 0.082
  57. Buprenorphine for cocaine and opiate dependence. Psychopharmacol Bull. 1992; 28(1):15-9.
    View in: PubMed
    Score: 0.082
  58. Pharmacotherapy improves treatment outcome in depressed cocaine addicts. J Psychoactive Drugs. 1991 Oct-Dec; 23(4):417-25.
    View in: PubMed
    Score: 0.081
  59. Medications development and the war on drugs: victims of the Gulf war? Biol Psychiatry. 1991 Mar 15; 29(6):521-3.
    View in: PubMed
    Score: 0.078
  60. Depression as a prognostic factor for pharmacological treatment of cocaine dependence. Psychopharmacol Bull. 1991; 27(3):337-43.
    View in: PubMed
    Score: 0.077
  61. Anti-cocaine vaccine development. Expert Rev Vaccines. 2010 Sep; 9(9):1109-14.
    View in: PubMed
    Score: 0.075
  62. Neurobiology of abused drugs. Opioids and stimulants. J Nerv Ment Dis. 1990 Apr; 178(4):217-27.
    View in: PubMed
    Score: 0.073
  63. Mazindol treatment of cocaine abuse. A double-blind investigation. NIDA Res Monogr. 1990; 105:514.
    View in: PubMed
    Score: 0.072
  64. Cocaine symptoms are predicted by familial psychopathology. NIDA Res Monogr. 1990; 105:603-4.
    View in: PubMed
    Score: 0.072
  65. Evidence for altered desipramine disposition in methadone-maintained patients treated for cocaine abuse. Am J Drug Alcohol Abuse. 1990; 16(3-4):329-36.
    View in: PubMed
    Score: 0.072
  66. Cocaine abuse and opioid withdrawal. Lancet. 1989 Jul 15; 2(8655):165-6.
    View in: PubMed
    Score: 0.069
  67. Pharmacotherapeutic interventions for cocaine abuse. Matching patients to treatments. J Nerv Ment Dis. 1989 Jul; 177(7):379-89.
    View in: PubMed
    Score: 0.069
  68. Inpatient vs. outpatient cocaine abuse treatments. NIDA Res Monogr. 1989; 95:312-3.
    View in: PubMed
    Score: 0.067
  69. Buprenorphine treatment of cocaine abuse. NIDA Res Monogr. 1989; 95:461.
    View in: PubMed
    Score: 0.067
  70. Role of opioid antagonists in treating intravenous cocaine abuse. Life Sci. 1989; 44(13):887-92.
    View in: PubMed
    Score: 0.067
  71. Antecedents and consequences of cocaine abuse among opioid addicts. A 2.5-year follow-up. J Nerv Ment Dis. 1988 Mar; 176(3):176-81.
    View in: PubMed
    Score: 0.063
  72. Rapid death during cocaine abuse: a variant of the neuroleptic malignant syndrome? Am J Drug Alcohol Abuse. 1988; 14(3):335-46.
    View in: PubMed
    Score: 0.062
  73. A preliminary study of desipramine in the treatment of cocaine abuse in methadone maintenance patients. J Clin Psychiatry. 1987 Nov; 48(11):442-4.
    View in: PubMed
    Score: 0.062
  74. A 2.5-year follow-up of cocaine use among treated opioid addicts. Have our treatments helped? Arch Gen Psychiatry. 1987 Mar; 44(3):281-4.
    View in: PubMed
    Score: 0.059
  75. The dependence syndrome across different psychoactive substances: revised DSM-III. NIDA Res Monogr. 1987; 76:255-8.
    View in: PubMed
    Score: 0.058
  76. Emerging pharmacological strategies in the fight against cocaine addiction. Expert Opin Emerg Drugs. 2006 Mar; 11(1):91-8.
    View in: PubMed
    Score: 0.055
  77. Six-month trial of bupropion with contingency management for cocaine dependence in a methadone-maintained population. Arch Gen Psychiatry. 2006 Feb; 63(2):219-28.
    View in: PubMed
    Score: 0.055
  78. Cocaine withdrawal symptoms predict medication response in cocaine users. Am J Drug Alcohol Abuse. 2006; 32(4):617-27.
    View in: PubMed
    Score: 0.054
  79. Diagnosing depression with the DST and TRH in cocaine and opioid abusers. J Subst Abuse Treat. 1986; 3(1):47-9.
    View in: PubMed
    Score: 0.054
  80. Abuse of cocaine with opioids: psychological aspects of treatment. NIDA Res Monogr. 1986; 67:278-82.
    View in: PubMed
    Score: 0.054
  81. Cocaine abuse among opioid addicts: demographic and diagnostic factors in treatment. Am J Drug Alcohol Abuse. 1986; 12(1-2):1-16.
    View in: PubMed
    Score: 0.054
  82. Efficacy of dose and contingency management procedures in LAAM-maintained cocaine-dependent patients. Drug Alcohol Depend. 2005 Aug 01; 79(2):157-65.
    View in: PubMed
    Score: 0.053
  83. Disulfiram facilitates the development and expression of locomotor sensitization to cocaine in rats. Biol Psychiatry. 2003 Nov 01; 54(9):915-21.
    View in: PubMed
    Score: 0.047
  84. Tiagabine increases cocaine-free urines in cocaine-dependent methadone-treated patients: results of a randomized pilot study. Addiction. 2003 Nov; 98(11):1625-32.
    View in: PubMed
    Score: 0.047
  85. Therapeutic vaccines for substance dependence. Expert Rev Vaccines. 2002 Oct; 1(3):363-71.
    View in: PubMed
    Score: 0.043
  86. The OPRD1 rs678849 variant influences outcome of disulfiram treatment for cocaine dependency in methadone-maintained patients. Psychiatr Genet. 2021 06 01; 31(3):88-94.
    View in: PubMed
    Score: 0.039
  87. Sex differences in self-reported and physiological response to oral cocaine and placebo in humans. Am J Drug Alcohol Abuse. 2000 Nov; 26(4):643-57.
    View in: PubMed
    Score: 0.038
  88. Individual differences in humans responding under a cocaine discrimination procedure: discriminators versus nondiscriminators. Exp Clin Psychopharmacol. 1999 Nov; 7(4):391-8.
    View in: PubMed
    Score: 0.035
  89. [123I]beta-CIT SPECT imaging of dopamine transporter availability after mazindol administration in human cocaine addicts. Psychopharmacology (Berl). 1998 Jun; 137(4):321-5.
    View in: PubMed
    Score: 0.032
  90. Chronic disulfiram treatment effects on intranasal cocaine administration: initial results. Biol Psychiatry. 1998 Apr 01; 43(7):540-3.
    View in: PubMed
    Score: 0.032
  91. Moderators of response to sertraline versus placebo among recently abstinent, cocaine dependent patients: A retrospective analysis of two clinical trials. Am J Addict. 2017 Dec; 26(8):807-814.
    View in: PubMed
    Score: 0.031
  92. Effect of alpha-methyl-para-tyrosine on response to cocaine challenge. Biol Psychiatry. 1997 Aug 01; 42(3):181-90.
    View in: PubMed
    Score: 0.030
  93. Pharmacotherapy for opioid and cocaine abuse. Med Clin North Am. 1997 Jul; 81(4):909-25.
    View in: PubMed
    Score: 0.030
  94. Motivational factors in cocaine pharmacotherapy trials with methadone-maintained patients: problems and paradoxes. J Psychoactive Drugs. 1997 Apr-Jun; 29(2):205-12.
    View in: PubMed
    Score: 0.030
  95. Decreased digital flow persists after the abatement of cocaine-induced hemodynamic stimulation. Anesth Analg. 1997 Jan; 84(1):46-50.
    View in: PubMed
    Score: 0.029
  96. A multicenter trial of bupropion for cocaine dependence in methadone-maintained patients. Drug Alcohol Depend. 1995 Dec; 40(2):125-31.
    View in: PubMed
    Score: 0.027
  97. Desipramine, amantadine, or fluoxetine in buprenorphine-maintained cocaine users. J Subst Abuse Treat. 1995 Nov-Dec; 12(6):423-8.
    View in: PubMed
    Score: 0.027
  98. Mazindol treatment for cocaine dependence. Drug Alcohol Depend. 1995 Oct; 39(3):245-52.
    View in: PubMed
    Score: 0.027
  99. Cocaethylene: pharmacology, physiology and behavioral effects in humans. J Pharmacol Exp Ther. 1995 Jul; 274(1):215-23.
    View in: PubMed
    Score: 0.026
  100. Acupuncture for the treatment of cocaine addiction. Investigation of a needle puncture control. J Subst Abuse Treat. 1995 May-Jun; 12(3):195-205.
    View in: PubMed
    Score: 0.026
  101. Serotonergic mechanisms of cocaine effects in humans. Psychopharmacology (Berl). 1995 May; 119(2):179-85.
    View in: PubMed
    Score: 0.026
  102. Tryptophan depletion and attenuation of cue-induced craving for cocaine. Am J Psychiatry. 1995 May; 152(5):778-83.
    View in: PubMed
    Score: 0.026
  103. Differences between responders and nonresponders to cocaine cues in the laboratory. Addict Behav. 1995 Mar-Apr; 20(2):215-24.
    View in: PubMed
    Score: 0.026
  104. Platelet alpha-granule release in cocaine users. Circulation. 1994 Sep; 90(3):1162-7.
    View in: PubMed
    Score: 0.025
  105. Noradrenergic dysregulation during discontinuation of cocaine use in addicts. Arch Gen Psychiatry. 1994 Sep; 51(9):713-9.
    View in: PubMed
    Score: 0.025
  106. Changes concurrent with initiation of abstinence from cocaine abuse. J Subst Abuse Treat. 1993 Nov-Dec; 10(6):577-83.
    View in: PubMed
    Score: 0.023
  107. Concurrent cocaine-ethanol ingestion in humans: pharmacology, physiology, behavior, and the role of cocaethylene. Psychopharmacology (Berl). 1993; 111(1):39-46.
    View in: PubMed
    Score: 0.022
  108. Dopaminergic responsivity during cocaine abstinence: a pilot study. Psychiatry Res. 1992 Jul; 43(1):77-85.
    View in: PubMed
    Score: 0.021
  109. Buprenorphine: beyond methadone? Hosp Community Psychiatry. 1991 Apr; 42(4):347-9.
    View in: PubMed
    Score: 0.020
  110. The dependence syndrome concept as applied to alcohol and other substances of abuse. Recent Dev Alcohol. 1990; 8:47-68.
    View in: PubMed
    Score: 0.018
  111. Depressive symptoms during buprenorphine treatment of opioid abusers. J Subst Abuse Treat. 1990; 7(1):51-4.
    View in: PubMed
    Score: 0.018
  112. Desipramine facilitation of initial cocaine abstinence. Arch Gen Psychiatry. 1989 Feb; 46(2):117-21.
    View in: PubMed
    Score: 0.017
  113. Double-blind evaluation of the effect of acute amantadine on cocaine craving. Psychopharmacology (Berl). 1989; 97(3):402-3.
    View in: PubMed
    Score: 0.017
  114. Differential diagnosis of psychiatric comorbidity in substance abusers. J Subst Abuse Treat. 1988; 5(4):201-6.
    View in: PubMed
    Score: 0.016
  115. Elevated central serotonin transporter binding availability in acutely abstinent cocaine-dependent patients. Am J Psychiatry. 2000 Jul; 157(7):1134-40.
    View in: PubMed
    Score: 0.009
  116. A randomized trial of buprenorphine maintenance for heroin dependence in a primary care clinic for substance users versus a methadone clinic. Am J Med. 1998 Aug; 105(2):100-5.
    View in: PubMed
    Score: 0.008
  117. Elevated striatal dopamine transporters during acute cocaine abstinence as measured by [123I] beta-CIT SPECT. Am J Psychiatry. 1998 Jun; 155(6):832-4.
    View in: PubMed
    Score: 0.008
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.